Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2005;64:153-155; doi:10.1136/ard.2003.019323
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2005;64:153-155
© 2005 by BMJ Publishing Group Ltd & European League Against Rheumatism

CONCISE REPORT

Lupus erythematosus with leflunomide: induction or reactivation?

D Gensburger1, M Kawashima1, H Marotte1, J Kanitakis2 and P Miossec1

1 Departments of Immunology and Rheumatology and Hospices Civils de Lyon-bioMérieux Research Unit on Rheumatoid Arthritis, Hôpital Edouard Hérriot, Lyon, France
2 Department of Dermatology, Hôpital Edouard Hérriot, Lyon, France

Correspondence to:
Correspondence to:
Professor P Miossec
Clinical Immunology Unit, Departments of Immunology and Rheumatology, Hôpital Edouard Hérriot, 69437 Lyon Cedex 03, France; miossec{at}univ-lyon1.fr

ABSTRACT

Background: Leflunomide is a new oral disease modifying antirheumatic drug with a good safety profile.

Case report: The first case of lupus erythematosus in a 58 year old white woman after administration of leflunomide for primary Sjögren’s syndrome is reported. The relationship between induced lupus and leflunomide was confirmed by the resolution of the skin rash when the drug was stopped and its recurrence when it was reintroduced following a dose-response effect.

Discussion: Peripheral blood cells from this patient, from 15 patients with rheumatoid arthritis, and from healthy controls were used in a bioassay, which suggested that leflunomide affected the Th1/Th2 balance. Such a side effect might be related, in part, to the anti-tumour necrosis factor {alpha} activity of leflunomide.

Abbreviations: ELISA, enzyme linked immunosorbent assay; ENA, extractable nuclear antigen; IFN{gamma}, interferon {gamma}; IL, interleukin; PBMC, peripheral blood mononuclear cells; RA, rheumatoid arthritis; TNF{alpha}, tumour necrosis factor {alpha}

Keywords: leflunomide; lupus; side effects; Th1/Th2 balance


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Martin, J., Ricart, J., Alcacer, J, Rausell, N, Arana, G (2008). Adalimumab-induced lupus erythematosus. Lupus 17: 676-678 [Abstract]  
  • Marzano, A., Ramoni, S, Del Papa, N, Barbareschi, M, Alessi, E (2008). Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. Lupus 17: 329-331 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs